Apheresis Market by Product, Componentand End User- Global Industry Analysis & Forecast to 2027
Published On : April 2019 Pages : 180 Category: Medical Devices Report Code : HC043431
Apheresis Market by Product (Software, Devices, Disposable & Reagents) Component (Leukocytes (Leukapheresis), Lymphocytes (Lymph Apheresis),Plasma (Plasmapheresis), Platelets (Plateletpheresis), RBC's (Erythropheresis) End User(Hospitals, Blood Centers, Others) - Global Industry Analysis & Forecast to 2027
Industry Outlook and Trend Analysis
Apheresis is a procedure through which at least one blood segments can be acquired by handling of blood utilizing an apheresis framework. The rest of the parts are then come back to the benefactor or patient either amid the procedure or toward the finish of the procedure.
Drivers and Restraints
The key factors that support the development of the worldwide apheresis showcase incorporate upsurge sought after for blood parts over the globe and increment in government activities towards blood gift. Likewise, recently endorsed signs for apheresis treatment, for example, intense spread encephalomyelitis, immune system hemolytic sickliness, and cardiovascular neonatal lupus supplement the market development. Be that as it may, lack of talented experts and confusions related with the apheresis strategy are relied upon to hamper the market development. Then again, ascend sought after for plasma-determined pharmaceuticals offer gainful open doors for the extension of the market.
Regional Insights
North America commanded the market in 2017, representing most elevated offer, and is foreseen to keep up this pattern all through the figure time frame. In any case, Asia-Pacific is anticipated to enlist the most elevated development rate from 2021 to 2027.
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- SouthAmerica
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA
Competitive Analysis
The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
- Asahi Kasei Medical Co., Ltd
- Terumo BCT, Inc.
- B. Braun Melsungen AG
- Fresenius Kabi
- Cerus Corporation
- Kawasumi Laboratories Inc.
- Haemonetics Corporation
- HemaCare Corporation
- Kaneka Corporation
- Nikkiso Co., Ltd
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2017 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
· Apheresis Market, By Product, Estimates and Forecast, 2017-2027 ($Million)
o Software
o Devices
o Disposable & Reagents
· Apheresis Market, By Component, Estimates and Forecast, 2017-2027 ($Million)
o Leukocytes (Leukapheresis)
o Lymphocytes (Lymph Apheresis)
o Plasma (Plasmapheresis)
o Platelets (Plateletpheresis)
o RBC's (Erythropheresis)
· Apheresis Market, By End User, Estimates and Forecast, 2017-2027 ($Million)
o Hospitals
o Blood Centers
o Others
· Apheresis Market, By Key Players
o Asahi Kasei Medical Co., Ltd
o Terumo BCT, Inc.
o B. Braun Melsungen AG
o Fresenius Kabi
o Cerus Corporation
o Kawasumi Laboratories Inc.
o Haemonetics Corporation
o HemaCare Corporation
o Kaneka Corporation
o Nikkiso Co., Ltd
· Apheresis Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
o North America
§ North America Apheresis Market, By Country
o U.S. Apheresis Market
o Canada Apheresis Market
o Mexico Apheresis Market
o Europe
§ Europe Apheresis Market, By Country
o Germany Apheresis Market
o UK Apheresis Market
o France Apheresis Market
o Russia Apheresis Market
o Italy Apheresis Market
o Rest of Europe Apheresis Market
o Asia-Pacific
§ Asia-Pacific Apheresis Market, By Country
o China Apheresis Market
o Japan Apheresis Market
o South Korea Apheresis Market
o India Apheresis Market
o Southeast Asia Apheresis Market
o Rest of Asia-Pacific Apheresis Market
o South America
§ South America Apheresis Market
o Brazil Apheresis Market
o Argentina Apheresis Market
o Columbia Apheresis Market
o Rest of South America Apheresis Market
o Middle East and Africa
§ Middle East and Africa Apheresis Market
o Saudi Arabia Apheresis Market
o UAE Apheresis Market
o Egypt Apheresis Market
o Nigeria Apheresis Market
o South Africa Apheresis Market
o Rest of MEA Apheresis Market
Table of Contents:
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. SWOT Analysis
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. Apheresis Market, By Product
5.1. Introduction
5.2. Global Apheresis Revenue and Market Share by Product (2017-2027)
5.2.1. Global Apheresis Revenue and Revenue Share by Product (2017-2027)
5.3. Software
5.3.1. Global Software Revenue and Growth Rate (2017-2027)
5.4. Devices
5.4.1. Global Devices Revenue and Growth Rate (2017-2027)
5.5. Disposable & Reagents
5.5.1. Global Disposable & Reagents Revenue and Growth Rate (2017-2027)
6. Apheresis Market, By Component
6.1. Introduction
6.2. Global Apheresis Revenue and Market Share by Component (2017-2027)
6.2.1. Global Apheresis Revenue and Revenue Share by Component (2017-2027)
6.3. Leukocytes (Leukapheresis)
6.3.1. Global Leukocytes (Leukapheresis) Revenue and Growth Rate (2017-2027)
6.4. Lymphocytes (Lymph Apheresis)
6.4.1. Global Lymphocytes (Lymph Apheresis) Revenue and Growth Rate (2017-2027)
6.5. Plasma (Plasmapheresis)
6.5.1. Global Plasma (Plasmapheresis) Revenue and Growth Rate (2017-2027)
6.6. Platelets (Plateletpheresis)
6.6.1. Global Platelets (Plateletpheresis) Revenue and Growth Rate (2017-2027)
6.7. RBC's (Erythropheresis)
6.7.1. Global RBC's (Erythropheresis) Revenue and Growth Rate (2017-2027)
7. Apheresis Market, By End User
7.1. Introduction
7.2. Global Apheresis Revenue and Market Share by End User (2017-2027)
7.2.1. Global Apheresis Revenue and Revenue Share by End User (2017-2027)
7.3. Hospitals
7.3.1. Global Hospitals Revenue and Growth Rate (2017-2027)
7.4. Blood Centers
7.4.1. Global Blood Centers Revenue and Growth Rate (2017-2027)
7.5. Others
7.5.1. Global Others Revenue and Growth Rate (2017-2027)
8. Apheresis Market, By Region
8.1. Introduction
8.2. Global Apheresis Revenue and Market Share by Regions
8.2.1. Global Apheresis Revenue by Regions (2017-2027)
8.3. North America Apheresis by Countries
8.3.1. North America Apheresis Revenue and Growth Rate (2017-2027)
8.3.2. North America Apheresis Revenue (Million USD) by Countries (2017-2027)
8.3.3. United States
8.3.3.1. United States Apheresis Revenue (Millions USD) and Growth Rate (2017-2027)
8.3.4. Canada
8.3.4.1. Canada Apheresis Revenue (Millions USD) and Growth Rate (2017-2027)
8.3.5. Mexico
8.3.5.1. Mexico Apheresis Revenue (Millions USD) and Growth Rate (2017-2027)
8.4. Europe Apheresis by Countries
8.4.1. Europe Apheresis Revenue and Growth Rate (2017-2027)
8.4.2. Europe Apheresis Revenue (Million USD) by Countries (2017-2027)
8.4.3. Germany
8.4.3.1. Germany Apheresis Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.4. France
8.4.4.1. France Apheresis Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.5. UK
8.4.5.1. UK Apheresis Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.6. Russia
8.4.6.1. Russia Apheresis Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.7. Italy
8.4.7.1. Italy Apheresis Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.8. Rest of Europe
8.4.8.1. Rest of Europe Apheresis Revenue (Millions USD) and Growth Rate (2017-2027)
8.5. Asia-Pacific Apheresis by Countries
8.5.1. Asia-Pacific Apheresis Revenue and Growth Rate (2017-2027)
8.5.2. Asia-Pacific Apheresis Revenue (Million USD) by Countries (2017-2027)
8.5.3. China
8.5.3.1. China Apheresis Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.4. Japan
8.5.4.1. Japan Apheresis Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.5. Korea
8.5.5.1. Korea Apheresis Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.6. India
8.5.6.1. India Apheresis Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.7. Southeast Asia
8.5.7.1. Southeast Asia Apheresis Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.8. Rest of Asia-Pacific
8.5.8.1. Rest of Asia-Pacific Apheresis Revenue (Millions USD) and Growth Rate (2017-2027)
8.6. South America Apheresis by Countries
8.6.1. South America Apheresis Revenue and Growth Rate (2017-2027)
8.6.2. South America Apheresis Revenue (Million USD) by Countries (2017-2027)
8.6.3. Brazil
8.6.3.1. Brazil Apheresis Revenue (Millions USD) and Growth Rate (2017-2027)
8.6.4. Argentina
8.6.4.1. Argentina Apheresis Revenue (Millions USD) and Growth Rate (2017-2027)
8.6.5. Columbia
8.6.5.1. Columbia Apheresis Revenue (Millions USD) and Growth Rate (2017-2027)
8.6.6. Rest of South America
8.6.6.1. Rest of South America Apheresis Revenue (Millions USD) and Growth Rate (2017-2027)
8.7. Middle East and Africa Apheresis by Countries
8.7.1. Middle East and Africa Apheresis Revenue and Growth Rate (2017-2027)
8.7.2. Middle East and Africa Apheresis Revenue (Million USD) by Countries (2017-2027)
8.7.3. Saudi Arabia
8.7.3.1. Saudi Arabia Apheresis Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.4. United Arab Emirates
8.7.4.1. United Arab Emirates Apheresis Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.5. Egypt
8.7.5.1. Egypt Apheresis Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.6. Nigeria
8.7.6.1. Nigeria Apheresis Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.7. South Africa
8.7.7.1. South Africa Apheresis Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.8. Turkey
8.7.8.1. Turkey Apheresis Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.9. Rest of Middle East and Africa
8.7.9.1. Rest of Middle East and Africa Apheresis Revenue (Millions USD) and Growth Rate (2017-2027)
9. Company Profiles
9.1. Asahi Kasei Medical Co., Ltd
9.1.1. Business Overview
9.1.2. Service Portfolio
9.1.3. Strategic Developments
9.1.4. Financial Overview
9.2. Terumo BCT, Inc.
9.2.1. Business Overview
9.2.2. Service Portfolio
9.2.3. Strategic Developments
9.2.4. Financial Overview
9.3. B. Braun Melsungen AG
9.3.1. Business Overview
9.3.2. Service Portfolio
9.3.3. Strategic Developments
9.3.4. Financial Overview
9.4. Fresenius Kabi
9.4.1. Business Overview
9.4.2. Service Portfolio
9.4.3. Strategic Developments
9.4.4. Financial Overview
9.5. Cerus Corporation
9.5.1. Business Overview
9.5.2. Service Portfolio
9.5.3. Strategic Developments
9.5.4. Financial Overview
9.6. Kawasumi Laboratories Inc.
9.6.1. Business Overview
9.6.2. Service Portfolio
9.6.3. Strategic Developments
9.6.4. Financial Overview
9.7. Haemonetics Corporation
9.7.1. Business Overview
9.7.2. Service Portfolio
9.7.3. Strategic Developments
9.7.4. Financial Overview
9.8. HemaCare Corporation
9.8.1. Business Overview
9.8.2. Service Portfolio
9.8.3. Strategic Developments
9.8.4. Financial Overview
9.9. Kaneka Corporation
9.9.1. Business Overview
9.9.2. Service Portfolio
9.9.3. Strategic Developments
9.9.4. Financial Overview
9.10. Nikkiso Co., Ltd
9.10.1. Business Overview
9.10.2. Service Portfolio
9.10.3. Strategic Developments
9.10.4. Financial Overview
10. Global Apheresis Market Competition, by Manufacturer
10.1. Global Apheresis Financial Overview by Manufacturer (2017-2017)
10.2. Global Apheresis Price By Region (2017-2017)
10.3. Top 5 Apheresis Manufacturer Market Share
10.4. Market Competition Trend
11. Apheresis Market Forecast (2017-2027)
11.1. Global Apheresis Revenue (Millions USD) and Growth Rate (2017-2027)
11.2. Apheresis Market Forecast by Regions (2017-2027)
11.2.1. North America Apheresis Market Forecast (2017-2027)
11.2.1.1. United States Apheresis Market Forecast (2017-2027)
11.2.1.2. Canada Apheresis Market Forecast (2017-2027)
11.2.1.3. Mexico Apheresis Market Forecast (2017-2027)
11.2.2. Europe Apheresis Market Forecast (2017-2027)
11.2.2.1. Germany Apheresis Market Forecast (2017-2027)
11.2.2.2. France Apheresis Market Forecast (2017-2027)
11.2.2.3. UK Apheresis Market Forecast (2017-2027)
11.2.2.4. Russia Apheresis Market Forecast (2017-2027)
11.2.2.5. Italy Apheresis Market Forecast (2017-2027)
11.2.2.6. Rest of Europe Apheresis Market Forecast (2017-2027)
11.2.3. Asia-Pacific Apheresis Market Forecast (2017-2027)
11.2.3.1. China Apheresis Market Forecast (2017-2027)
11.2.3.2. Japan Apheresis Market Forecast (2017-2027)
11.2.3.3. Korea Apheresis Market Forecast (2017-2027)
11.2.3.4. India Apheresis Market Forecast (2017-2027)
11.2.3.5. Southeast Asia Apheresis Market Forecast (2017-2027)
11.2.3.6. Rest of Asia-Pacific Apheresis Market Forecast (2017-2027)
11.2.4. South America Apheresis Market Forecast (2017-2027)
11.2.4.1. Brazil Apheresis Market Forecast (2017-2027)
11.2.4.2. Argentina Apheresis Market Forecast (2017-2027)
11.2.4.3. Columbia Apheresis Market Forecast (2017-2027)
11.2.4.4. Rest of South America Apheresis Market Forecast (2017-2027)
11.2.5. Middle East and Africa Apheresis Market Forecast (2017-2027)
11.2.5.1. Saudi Arabia Apheresis Market Forecast (2017-2027)
11.2.5.2. United Arab Emirates Apheresis Market Forecast (2017-2027)
11.2.5.3. Egypt Apheresis Market Forecast (2017-2027)
11.2.5.4. Nigeria Apheresis Market Forecast (2017-2027)
11.2.5.5. South Africa Apheresis Market Forecast (2017-2027)
11.2.5.6. Turkey Apheresis Market Forecast (2017-2027)
11.2.5.7. Rest of Middle East and Africa Apheresis Market Forecast (2017-2027)
11.3. Apheresis Market Forecast by Product (2017-2027)
11.3.1. Apheresis Forecast by Product (2017-2027)
11.3.2. Apheresis Market Share Forecast by Product (2017-2027)
11.4. Apheresis Market Forecast by Component (2017-2027)
11.4.1. Apheresis Forecast by Component (2017-2027)
11.4.2. Apheresis Market Share Forecast by Component (2017-2027)
11.5. Apheresis Market Forecast by End User (2017-2027)
11.5.1. Apheresis Forecast by End User (2017-2027)
11.5.2. Apheresis Market Share Forecast by End User (2017-2027)
List of Tables
List of Tables and Figures:
Figure United States Apheresis Revenue (Million USD) and Growth Rate (2017-2025)
Figure Canada Apheresis Revenue (Million USD) and Growth Rate (2017-2025)
Figure Mexico Apheresis Revenue (Million USD) and Growth Rate (2017-2025)
Figure Germany Apheresis Revenue (Million USD) and Growth Rate (2017-2025)
Figure France Apheresis Revenue (Million USD) and Growth Rate (2017-2025)
Figure UK Apheresis Revenue (Million USD) and Growth Rate (2017-2025)
Figure Russia Apheresis Revenue (Million USD) and Growth Rate (2017-2025)
Figure Italy Apheresis Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Europe Apheresis Revenue (Million USD) and Growth Rate (2017-2025)
Figure China Apheresis Revenue (Million USD) and Growth Rate (2017-2025)
Figure Japan Apheresis Revenue (Million USD) and Growth Rate (2017-2025)
Figure Korea Apheresis Revenue (Million USD) and Growth Rate (2017-2025)
Figure India Apheresis Revenue (Million USD) and Growth Rate (2017-2025)
Figure Southeast Asia Apheresis Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Asia-Pacific Apheresis Revenue (Million USD) and Growth Rate (2017-2025)
Figure Brazil Apheresis Revenue (Million USD) and Growth Rate (2017-2025)
Figure Argentina Apheresis Revenue (Million USD) and Growth Rate (2017-2025)
Figure Columbia Apheresis Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of South America Apheresis Revenue (Million USD) and Growth Rate (2017-2025)
Figure Saudi Arabia Apheresis Revenue (Million USD) and Growth Rate (2017-2025)
Figure United Arab Emirates Apheresis Revenue (Million USD) and Growth Rate (2017-2025)
Figure Egypt Apheresis Revenue (Million USD) and Growth Rate (2017-2025)
Figure Nigeria Apheresis Revenue (Million USD) and Growth Rate (2017-2025)
Figure South Africa Apheresis Revenue (Million USD) and Growth Rate (2017-2025)
Figure Turkey Apheresis Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Middle East and Africa Apheresis Revenue (Million USD) and Growth Rate (2017-2025)
Table Global Apheresis Revenue and Revenue Share by Product (2017-2018)
Figure Global Software Revenue and Growth Rate (2017-2018)
Figure Global Devices Revenue and Growth Rate (2017-2018)
Figure Global Disposable & Reagents Revenue and Growth Rate (2017-2018)
Table Global Apheresis Revenue and Revenue Share by Component (2017-2018)
Figure Global Leukocytes (Leukapheresis) Revenue and Growth Rate (2017-2018)
Figure Global Lymphocytes (Lymph Apheresis) Revenue and Growth Rate (2017-2018)
Figure Global Plasma (Plasmapheresis) Revenue and Growth Rate (2017-2018)
Figure Global Platelets (Plateletpheresis) Revenue and Growth Rate (2017-2018)
Figure Global RBC's (Erythropheresis) Revenue and Growth Rate (2017-2018)
Table Global Apheresis Revenue and Revenue Share by End User (2017-2018)
Figure Global Hospitals Revenue and Growth Rate (2017-2018)
Figure Global Blood Centers Revenue and Growth Rate (2017-2018)
Figure Global Others Revenue and Growth Rate (2017-2018)
Table Global Apheresis Revenue by Regions (2017-2018)
Figure North America Apheresis Growth Rate (2017-2018)
Figure North America Apheresis Revenue and Growth Rate (2017-2018)
Figure North America Apheresis by Countries (2017-2018)
Figure North America Apheresis Revenue (Million USD) by Countries (2017-2018)
Figure United States Apheresis Growth Rate (2017-2018)
Figure United States Apheresis Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Canada Apheresis Growth Rate (2017-2018)
Figure Canada Apheresis Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Mexico Apheresis Growth Rate (2017-2018)
Figure Mexico Apheresis Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Europe Apheresis Growth Rate (2017-2018)
Figure Europe Apheresis Revenue and Growth Rate (2017-2018)
Figure Europe Apheresis by Countries (2017-2018)
Figure Europe Apheresis Revenue (Million USD) by Countries (2017-2018)
Figure Germany Apheresis Growth Rate (2017-2018)
Figure Germany Apheresis Revenue (Millions USD) and Growth Rate (2017-2018)
Figure France Apheresis Growth Rate (2017-2018)
Figure France Apheresis Revenue (Millions USD) and Growth Rate (2017-2018)
Figure UK Apheresis Growth Rate (2017-2018)
Figure UK Apheresis Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Russia Apheresis Growth Rate (2017-2018)
Figure Russia Apheresis Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Italy Apheresis Growth Rate (2017-2018)
Figure Italy Apheresis Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Europe Apheresis Growth Rate (2017-2018)
Figure Rest of Europe Apheresis Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Asia-Pacific Apheresis Growth Rate (2017-2018)
Figure Asia-Pacific Apheresis Revenue and Growth Rate (2017-2018)
Figure Asia-Pacific Apheresis by Countries (2017-2018)
Figure Asia-Pacific Apheresis Revenue (Million USD) by Countries (2017-2018)
Figure China Apheresis Growth Rate (2017-2018)
Figure China Apheresis Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Japan Apheresis Growth Rate (2017-2018)
Figure Japan Apheresis Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Korea Apheresis Growth Rate (2017-2018)
Figure Korea Apheresis Revenue (Millions USD) and Growth Rate (2017-2018)
Figure India Apheresis Growth Rate (2017-2018)
Figure India Apheresis Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Southeast Asia Apheresis Growth Rate (2017-2018)
Figure Southeast Asia Apheresis Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Apheresis Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Apheresis Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South America Apheresis Growth Rate (2017-2018)
Figure South America Apheresis Revenue and Growth Rate (2017-2018)
Figure South America Apheresis by Countries (2017-2018)
Figure South America Apheresis Revenue (Million USD) by Countries (2017-2018)
Figure Brazil Apheresis Growth Rate (2017-2018)
Figure Brazil Apheresis Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Argentina Apheresis Growth Rate (2017-2018)
Figure Argentina Apheresis Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Columbia Apheresis Growth Rate (2017-2018)
Figure Columbia Apheresis Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of South America Apheresis Growth Rate (2017-2018)
Figure Rest of South America Apheresis Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Middle East and Africa Apheresis Growth Rate (2017-2018)
Figure Middle East and Africa Apheresis Revenue and Growth Rate (2017-2018)
Figure Middle East and Africa Apheresis by Countries (2017-2018)
Figure Middle East and Africa Apheresis Revenue (Million USD) by Countries (2017-2018)
Figure Saudi Arabia Apheresis Growth Rate (2017-2018)
Figure Saudi Arabia Apheresis Revenue (Millions USD) and Growth Rate (2017-2018)
Figure United Arab Emirates Apheresis Growth Rate (2017-2018)
Figure United Arab Emirates Apheresis Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Egypt Apheresis Growth Rate (2017-2018)
Figure Egypt Apheresis Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Nigeria Apheresis Growth Rate (2017-2018)
Figure Nigeria Apheresis Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South Africa Apheresis Growth Rate (2017-2018)
Figure South Africa Apheresis Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Turkey Apheresis Growth Rate (2017-2018)
Figure Turkey Apheresis Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Apheresis Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Apheresis Revenue (Millions USD) and Growth Rate (2017-2018)
Table Asahi Kasei Medical Co., Ltd Apheresis Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Terumo BCT, Inc. Apheresis Price, Revenue, Gross Margin and Market Share (2017-2017)
Table B. Braun Melsungen AG Apheresis Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Fresenius Kabi Apheresis Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Cerus Corporation Apheresis Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Kawasumi Laboratories Inc. Apheresis Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Haemonetics Corporation Apheresis Price, Revenue, Gross Margin and Market Share (2017-2017)
Table HemaCare Corporation Apheresis Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Kaneka Corporation Apheresis Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Nikkiso Co., Ltd Apheresis Price, Revenue, Gross Margin and Market Share (2017-2017)
Figure Global Apheresis Market Share by Manufacturer
Figure Global Apheresis Revenue and Market Share by Manufacturer
Table Global Apheresis Price by Region (2017-2017)
Figure Top 5 Apheresis Manufacturer (Revenue) Market Share
Figure Market Competition Trend
Figure Global Apheresis Revenue (Millions USD) and Growth Rate (2018-2025)
Table Apheresis Market Forecast by Regions (2018-2025)
Figure North America Apheresis Market Forecast (2018-2025)
Figure United States Apheresis Market Forecast (2018-2025)
Figure Canada Apheresis Market Forecast (2018-2025)
Figure Mexico Apheresis Market Forecast (2018-2025)
Figure Europe Apheresis Market Forecast (2018-2025)
Figure Germany Apheresis Market Forecast (2018-2025)
Figure France Apheresis Market Forecast (2018-2025)
Figure UK Apheresis Market Forecast (2018-2025)
Figure Russia Apheresis Market Forecast (2018-2025)
Figure Italy Apheresis Market Forecast (2018-2025)
Figure Rest of Europe Apheresis Market Forecast (2018-2025)
Figure Asia-Pacific Apheresis Market Forecast (2018-2025)
Figure China Apheresis Market Forecast (2018-2025)
Figure Japan Apheresis Market Forecast (2018-2025)
Figure Korea Apheresis Market Forecast (2018-2025)
Figure India Apheresis Market Forecast (2018-2025)
Figure Southeast Asia Apheresis Market Forecast (2018-2025)
Figure Rest of Asia-Pacific Apheresis Market Forecast (2018-2025)
Figure South America Apheresis Market Forecast (2018-2025)
Figure Brazil Apheresis Market Forecast (2018-2025)
Figure Argentina Apheresis Market Forecast (2018-2025)
Figure Columbia Apheresis Market Forecast (2018-2025)
Figure Rest of South America Apheresis Market Forecast (2018-2025)
Figure Middle East and Africa Apheresis Market Forecast (2018-2025)
Figure Saudi Arabia Apheresis Market Forecast (2018-2025)
Figure United Arab Emirates Apheresis Market Forecast (2018-2025)
Figure Egypt Apheresis Market Forecast (2018-2025)
Figure Nigeria Apheresis Market Forecast (2018-2025)
Figure South Africa Apheresis Market Forecast (2018-2025)
Figure Turkey Apheresis Market Forecast (2018-2025)
Figure Rest of Middle East and Africa Apheresis Market Forecast (2018-2025)
Figure Global Apheresis Forecast by Product (2018-2025)
Figure Global Apheresis Market Share Forecast by Product (2018-2025)
Figure Global Apheresis Forecast by Product (2018-2025)
Figure Global Apheresis Forecast by Component (2018-2025)
Figure Global Apheresis Market Share Forecast by Component (2018-2025)
Figure Global Apheresis Forecast by Component (2018-2025)
Figure Global Apheresis Forecast by End User (2018-2025)
Figure Global Apheresis Market Share Forecast by End User (2018-2025)
Figure Global Apheresis Forecast by End User (2018-2025)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|